How Much Is Too Much? Patterns of Drinking During Alcohol Treatment and Associations With Post-Treatment Outcomes Across Three Alcohol Clinical Trials.
- Authors
- Witkiewitz, Katie; Roos, Corey R; Pearson, Matthew R; Hallgren, Kevin A; Maisto, Stephen A; Kirouac, Megan; Forcehimes, Alyssa A; Wilson, Adam D; Robinson, Charles S; McCallion, Elizabeth; Tonigan, J Scott; Heather, Nick
- Year
- 2017
- Journal
- Journal of studies on alcohol and drugs
- PMID
- 27936365
- DOI
- 10.15288/jsad.2017.78.59
- PMCID
- PMC5148751
OBJECTIVE: This secondary data analysis examined patterns of drinking during alcohol treatment and associated drinking outcomes during the first year following treatment. The goal was to provide clinicians with guidance on which patients may be most at risk for negative long-term outcomes based on drinking patterns during treatment. METHOD: This study was an analysis of existing data (N = 3,851) from three randomized clinical trials for alcohol use disorder: the COMBINE Study (n = 1,383), Project MATCH (n = 1,726), and the United Kingdom Alcohol Treatment Trial (n = 742). Indicators of abstinence, non-heavy drinking, and heavy drinking (defined as 4/5 or more drinks per day for women/men) were examined during each week of treatment using repeated-measures latent class analysis. Associations between drinking patterns during treatment and drinking intensity, drinking consequences, and physical and mental health 12 months following intake were examined. RESULTS: Seven drinking patterns were identified. Patients who engaged in persistent heavy drinking throughout treatment and those who returned to persistent heavy drinking during treatment had the worst long-term outcomes. Patients who engaged in some heavy drinking during treatment had better long-term outcomes than persistent heavy drinkers. Patients who reported low-risk drinking or abstinence had the best long-term outcomes. There were no differences in outcomes between low-risk drinkers and abstainers. CONCLUSIONS: Abstinence, low-risk drinking, or even some heavy drinking during treatment are associated with the best long-term outcomes. Patients who are engaging in persistent heavy drinking are likely to have the worst outcomes and may require a higher level of care.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| How changes in post-traumatic stress disorder (PTSD) severity mediate substance use disorder (SUD) severity during and after treatment for co-occurring PTSD and SUD: Results from Project Harmony. | Hien DA et al. | β | 2025 | β |
| Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study. | Bouthillier A et al. | β | 2025 | β |
| Potential predictors affecting outcomes in a randomized controlled trial of support programs for parents of young adults with hazardous substance use. | Siljeholm O et al. | β | 2025 | β |
| Prevalence, predictors, correlates, and dynamic changes in the NIAAA-defined "recovery" definition. | Kelly JF et al. | β | 2025 | β |
| Prospective examination of how alcohol consumption might drive changes in urgency and drinking motives over the first year of college. | Prestigiacomo CJ et al. | β | 2025 | β |
| Couple-Focused Smartphone Intervention to Reduce Problem Drinking: Pilot Randomized Control Trial. | Gustafson DH et al. | β | 2024 | β |
| Predictors of treatment outcome for individuals with alcohol use disorder with a goal of controlled drinking. | Ingesson-Hammarberg S et al. | β | 2024 | β |
| Regional cortical brain volumes at treatment entry relates to post treatment WHO risk drinking levels in those with alcohol use disorder. | Durazzo TC et al. | β | 2024 | β |
| Standardized Models for Identification and Intervention for Emergency Department Patients at Risk for Alcohol Use Disorder. | Gutierrez F | β | 2023 | β |
| Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints. | Borodovsky JT et al. | β | 2022 | β |
| Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels. | Nieto SJ et al. | β | 2022 | β |
| Effects of arousal modulation via resonance breathing on craving and affect in women with substance use disorder. | Price JL et al. | β | 2022 | β |
| Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder. | Sherman BJ et al. | β | 2022 | β |
| Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorder. | Kranzler HR et al. | β | 2021 | β |
| Heterogeneity in DSM-5 Symptom Criteria: Phenotypes of Alcohol Use Disorder in a Sample Seeking Alcohol Treatment. | Zhao J et al. | β | 2021 | β |
| Using peers to increase veterans' engagement in a smartphone application for unhealthy alcohol use: A pilot study of acceptability and utility. | Blonigen DM et al. | β | 2021 | β |
| What do clinicians want? Understanding frontline addiction treatment clinicians' preferences and priorities to improve the design of measurement-based care technology. | Tauscher JS et al. | β | 2021 | β |
| Within-AUD outpatient treatment heavy drinking transitions and associations with long-term outcomes. | Maisto SA et al. | β | 2021 | β |
| World Health Organization risk drinking levels as a treatment outcome measure in topiramate trials. | Hartwell EE et al. | β | 2021 | β |
| Changes in DSM criteria following a culturally-adapted computerized CBT for Spanish-speaking individuals with substance use disorders. | Silva MA et al. | β | 2020 | β |
| Pharmacologic treatment of alcohol use disorder. | Finley CR et al. | β | 2020 | β |
| Preresolution Drinking Problem Severity Profiles Associated with Stable Moderation Outcomes of Natural Recovery Attempts. | Tucker JA et al. | β | 2020 | β |
| Remission From Unhealthy Drinking Among Patients With an Alcohol Use Disorder: A Longitudinal Study Using Systematic, Primary Care-Based Alcohol Screening Data. | Palzes VA et al. | β | 2020 | β |
| Traitement pharmacologique du trouble de consommation dβalcool. | Finley CR et al. | β | 2020 | β |
| Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder. | Roos CR et al. | β | 2019 | β |
| Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials. | Falk DE et al. | β | 2019 | β |
| Patterns of Cocaine Use During Treatment: Associations With Baseline Characteristics and Follow-Up Functioning. | Roos CR et al. | β | 2019 | β |
| Trait self-control predicts drinking patterns during treatment for alcohol use disorder and recovery up to three years following treatment. | Stein E et al. | β | 2019 | β |
| A 22-Year Follow-Up (Range 16 to 23) of Original Subjects with Baseline Alcohol Use Disorders from the Collaborative Study on Genetics of Alcoholism. | Schuckit MA et al. | β | 2018 | β |
| Abstinence and low risk drinking during treatment: Association with psychosocial functioning, alcohol use, and alcohol problems 3 years following treatment. | Witkiewitz K et al. | β | 2018 | β |
| Change in DSM-5 Alcohol Use Disorder Criteria Count and Severity Level as a Treatment Outcome Indicator: Results from a Randomized Trial. | Kiluk BD et al. | β | 2018 | β |
| Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder. | Witkiewitz K et al. | β | 2018 | β |
| Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels. | Witkiewitz K et al. | β | 2017 | β |
| Commentary on Witkiewitz et al. (2017): Abstinence or moderation-a choice for whom and why? | StorbjΓΆrk J | β | 2017 | β |
| Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE Study. | Witkiewitz K et al. | β | 2017 | β |
| Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials. | Witkiewitz K et al. | β | 2017 | β |
| Do Alcohol Relapse Episodes During Treatment Predict Long-Term Outcomes? Investigating the Validity of Existing Definitions of Alcohol Use Disorder Relapse. | Maisto SA et al. | β | 2016 | β |